X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

HUMAW

Closed

Humacyte Inc

0.42
0.00 (0.00%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 0.42
Day's Range: 0.3501 - 0.42
Send
When Written:
 
0.6
Humacyte Inc is a biotechnology company that is focused on developing and manufacturing bioengineered human tissues for use in regenerative medicine and clinical research. The company was founded in 2004 and is headquartered in Durham, North Carolina.

Humacyte's proprietary technology platform involves the use of human-derived extracellular matrix (ECM) scaffolds that are seeded with human cells to create functional tissues. These tissues can be used to replace or repair damaged or diseased tissues in the body, such as blood vessels, heart valves, and kidney tissue.

Humacyte has several ongoing clinical trials for its bioengineered tissues, including a Phase III trial for its human acellular vessels (HAVs) for use in hemodialysis access and a Phase II trial for its bioengineered heart valves. The company has also partnered with several pharmaceutical and medical device companies to develop and commercialize its products.

Humacyte has received significant funding from investors, including the Bill and Melinda Gates Foundation, and has been recognized for its innovative technology and potential to transform the field of regenerative medicine.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X